首页> Clinical cancer research : an official journal of the American Association for Cancer Research> Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax.

Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax.

导出 OA

翻译打印收藏纠错

第一作者： Alexandre,Bazinet

第一单位： Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

作者： Alexandre,Bazinet ^[1] ; Sai Prasad,Desikan ^[1] ; Ziyi,Li ^[2] ; Juan Jose,Rodriguez-Sevilla ^[1] ; Sangeetha,Venugopal ^[3] ; Samuel,Urrutia ^[4] ; Guillermo,Montalban-Bravo ^[1] ; Koji,Sasaki ^[1] ; Kelly S,Chien ^[1] ; Danielle,Hammond ^[1] ; Rashmi,Kanagal-Shamanna ^[5] ; Irene,Ganan-Gomez ^[1] ; Tapan M,Kadia ^[1] ; Gautam,Borthakur ^[1] ; Courtney D,DiNardo ^[1] ; Naval G,Daver ^[1] ; Elias J,Jabbour ^[1] ; Farhad,Ravandi ^[1] ; Hagop,Kantarjian ^[1] ; Guillermo,Garcia-Manero ^[1]

作者单位： Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[1] Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[2] Department of Leukemia, The University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida. ^[3] Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[4] Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[5]